The Chimeric Therapeutics Ltd (ASX: CHM) share price edged higher in the final hour, before falling flat today. This comes despite the company releasing its quarterly update to the ASX towards the latter part of the afternoon.
At the end of today’s market wrap, the biotechnology company’s shares finished the day flat at 28.5 cents.
How did Chimeric perform?
Investors led Chimeric shares to close the day unchanged despite the company recapping its achievements and providing a financial update.
In the release, Chimeric reported a number of highlights, signalling why its shares have surged since listing on the ASX.
Chimeric declared $23.6…